NCT01487369View on ClinicalTrials.gov

Special Survey of Production of Insulin Aspart Specific Antibody

CompletedOBSERVATIONAL

Enrollment

204

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Injected subcutaneously (s.c., under the skin). Prescribed by physician as a result of normal clinical practice.

Trial Locations (1)

1000005

Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01487369 - Special Survey of Production of Insulin Aspart Specific Antibody | Biotech Hunter | Biotech Hunter